Cite
HARVARD Citation
Lopetuso, L. et al. (2018). The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease. Expert opinion on investigational drugs. pp. 543-551. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lopetuso, L. et al. (2018). The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease. Expert opinion on investigational drugs. pp. 543-551. [Online].